DADA ADEYEMI OLUWASEUN

Chemical Pathology

At the Chemical Pathology department office

Appointment on Visitation important

Topic: Serum Insulin Like Growth Factor 1 And C Reactive Protein In Metabolic Syndrome Patients

Description:

AIM

To determine serum levels of IGF 1, CRP, Zinc in MetS participants and healthy controls as well as   relate same with IR and other criteria of metabolic syndrome.

 

OBJECTIVES

1.    To measure serum IGF 1 levels among MetS participants and healthy controls

2.    To measure serum CRP levels among MetS participants and healthy controls

3.    To measure serum insulin and glucose as well as calculate Insulin Resistance (IR) using the Homeostatic Model Assessment Index for IR  (HOMA-IR) among MetS and healthy controls

4.    To measure Lipid, Blood Pressure and  Waist Circumference among MetS and compare with healthy controls.

 

#	Certificate	School	Year
1.	M.Sc (PUBLIC HEALTH)	UNIVERSITY OF SOUTH WALES; DEPARTMENT OF PUBLIC HEALTH	2023

SERUM ZINC LEVELS IN METABOLIC SYNDROME PATIENTS IN SOUTH WEST NIGERIA

Metabolic Syndrome (MetS) is a growing concern not only in developed countries but also in the developing countries owing to the increasing urbanisation. Metabolic Syndrome has also been referred to as the co-existence of several cardiovascular risk factors which have a mutual relationship and have common underlying mediators, mechanisms and course of events. These risk factors include Insulin Resistance (IR), Obesity, atherogenic dyslipidemia and hypertension.

Insulin Resistance has been identified as one of the key players in both onset and progression of MetS.  Zinc which has been noted to have a wide range of metabolic and immunologic effects is required for insulin storage and secretion as well as an insulin like action. To this end, determination of zinc level is germane to the pathophysiology of metabolic syndrome.

To this end, determination of zinc level is germane to the pathophysiology of metabolic syndrome. This will be related to components of metabolic syndrome in patients and controls. We will measure serum Insulin, zinc, triglyceride, HDL-cholesterol, glucose levels in participants with MetS and matched healthy controls

 

DADA ADEYEMI is a Lecturer I at the Department of Chemical Pathology

DADA has a M.Sc in PUBLIC HEALTH from UNIVERSITY OF SOUTH WALES; DEPARTMENT OF PUBLIC HEALTH